Nyxoah today announced a significant reimbursement win through the U.S. Centers for Medicare & Medicaid Services (CMS).

“How Dental Sleep Medicine Expert Dr. Monica M. Pierpan of Hampstead Explains Sleep Apnea Treatment for HelloNation” features ...

Airway Management, the innovator behind TAP Sleep Care and a leader in advanced oral appliance therapy, today announced that its groundbreaking Nylon flexTAP(R) has received Pricing, Data Analysis, ...

Airway Management remains the only company supported by over 50 independent peer-reviewed studies – more than any competitor – demonstrating proven efficacy in treating sleep-disordered breathing. The ...

Q3 2025 Earnings Call Transcript November 19, 2025 Vivos Therapeutics, Inc. beats earnings expectations. Reported EPS is ...

Discover key insights from Vivos Therapeutics’ Q3 2025 earnings: strategic growth, 76% revenue surge, and future outlook in sleep disorder treatment.

On vacation in Mexico last year, Michael DiPlacido passed out twice while scuba diving and again in his hotel. Back in St.

Q3 2025 Earnings Call November 19, 2025 5:00 PM ESTCompany ParticipantsBradford Amman - CFO, Treasurer & SecretaryR.

Germany: A new multicentre phase 2 clinical trial published in The Lancet has reported encouraging results for sultiame—a ...

Attorneys questioned a vice president from Sechrist Industries about the hyperbaric chamber that caught fire at the Oxford Center, killing a child.

A new oral GLP-1 medication can help adults with obesity and type 2 diabetes lose more weight and improve their blood sugar ...

The use of electrical stimulation of the upper airway to treat patients with obstructive sleep apnea (OSA) is supported by low-quality evidence.